The global Bacteriophage Therapy market was valued at US$ 33 million in 2022 and is projected to reach US$ 61 million by 2029, at a CAGR of 9.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
This report aims to provide a comprehensive presentation of the global market for Bacteriophage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage Therapy. This report contains market size and forecasts of Bacteriophage Therapy in global, including the following market information:
- Global Bacteriophage Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
We surveyed the Bacteriophage Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacteriophage Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bacteriophage Therapy Market Segment Percentages, by Type, 2022 (%)
Global Bacteriophage Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bacteriophage Therapy Market Segment Percentages, by Application, 2022 (%)
- Organ Transplantation
- Bacterial Infections
- Alcoholic Hepatitis
- Other
Global Bacteriophage Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bacteriophage Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bacteriophage Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Bacteriophage Therapy revenues share in global market, 2022 (%)
key players include:
- Armata Pharmaceuticals, Inc.
- Eliava Biopreparations Ltd.
- Pherecydes Pharma
- Intralytix, Inc.
- Phagelux Inc.
- Nextbiotics
- InnoPhage, Ltd
- Locus Biosciences, Inc.
- TechnoPhage
- Eligo Bioscience SA
- Phagomed Biopharma GmbH.
- PhagePro, Inc.
- Adaptive Phage Therapeutics, Inc.
- EnBiotix, Inc.
- Intodeworld, Inc.
- BiomX Ltd.
- Phi Therapeutics
- Fixed-phage Ltd.
- Micreos BV
- ContraFect Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bacteriophage Therapy, market overview.
Chapter 2: Global Bacteriophage Therapy market size in revenue.
Chapter 3: Detailed analysis of Bacteriophage Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacteriophage Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
